Ticker LaunchIPO · ITOS
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. (ITOS) priced its initial public offering on Jul 27, 2020 at $19.00 per share, above its $16.00–$18.00 range, raising $201.1M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $635.3M. Cooley advised the underwriters.
- Status
- IPO
- Ticker
- ITOS
- Exchange
- Nasdaq Global Market
- Priced
- Jul 27, 2020
- IPO price
- $19.00
- Price range
- $16.00–$18.00
- Raised
- $201.1M
- Market cap at IPO price
- $635.3M
- First filed
- Jun 24, 2020
- Underwriters' counsel
- Cooley
- Sector
- Biotech & pharma
- Country / state
- MA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jun 24, 2020
- Latest amendment Jul 20, 2020
- Final prospectus (424B4) Jul 27, 2020
- All filings on EDGAR CIK 1808865
Other Biotech & pharma IPOs in 2020
- Kalaris Therapeutics, Inc.ALVR · Jul 30, 2020 · $276.2M
- Annexon, Inc.ANNX · Jul 24, 2020 · $250.8M
- Inozyme Pharma, Inc.Jul 24, 2020 · $112M
- Nurix Therapeutics, Inc.NRIX · Jul 24, 2020 · $209M
- ALX Oncology Holdings IncALXO · Jul 17, 2020 · $161.5M
- Pandion Therapeutics, Inc.PAND · Jul 17, 2020 · $135M